19891699

Source:http://linkedlifedata.com/resource/pubmed/id/19891699

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0026764, umls-concept:C0035020, umls-concept:C0439831, umls-concept:C0681842, umls-concept:C0871261, umls-concept:C1414057, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C1831743, umls-concept:C2911692
pubmed:issue	3
pubmed:dateCreated	2010-2-16
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8703985
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Boronic Acids, http://linkedlifedata.com/resource/pubmed/chemical/DKK1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Melphalan, http://linkedlifedata.com/resource/pubmed/chemical/Myeloma Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines, http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/bortezomib
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1600-0609
pubmed:author	pubmed-author:AttalMichelM, pubmed-author:BourinPhilippeP, pubmed-author:LarocheMichelM, pubmed-author:LemaireOliviaO
pubmed:issnType	Electronic
pubmed:volume	84
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	276-7
pubmed:meshHeading	pubmed-meshheading:19891699-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19891699-Boronic Acids, pubmed-meshheading:19891699-Combined Modality Therapy, pubmed-meshheading:19891699-Dexamethasone, pubmed-meshheading:19891699-Doxorubicin, pubmed-meshheading:19891699-Female, pubmed-meshheading:19891699-Follow-Up Studies, pubmed-meshheading:19891699-Humans, pubmed-meshheading:19891699-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:19891699-Male, pubmed-meshheading:19891699-Melphalan, pubmed-meshheading:19891699-Middle Aged, pubmed-meshheading:19891699-Multiple Myeloma, pubmed-meshheading:19891699-Myeloma Proteins, pubmed-meshheading:19891699-Peripheral Blood Stem Cell Transplantation, pubmed-meshheading:19891699-Prognosis, pubmed-meshheading:19891699-Pyrazines, pubmed-meshheading:19891699-Recurrence, pubmed-meshheading:19891699-Thalidomide, pubmed-meshheading:19891699-Transplantation, Autologous, pubmed-meshheading:19891699-Tumor Markers, Biological, pubmed-meshheading:19891699-Vincristine
pubmed:year	2010
pubmed:articleTitle	DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.
pubmed:publicationType	Letter